Prognostic factors in ALS: a critical review
We have performed a systematic review to summarize current knowledge concerning factors
related to survival in ALS and to evaluate the implications of these data for clinical trials …
related to survival in ALS and to evaluate the implications of these data for clinical trials …
Reminiscence therapy for dementia
B Woods, L O'Philbin, EM Farrell… - … of systematic reviews, 2018 - cochranelibrary.com
Background This updated Cochrane Review of reminiscence therapy (RT) for dementia was
first published in 1998, and last updated in 2005. RT involves the discussion of memories …
first published in 1998, and last updated in 2005. RT involves the discussion of memories …
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal
Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve …
Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve …
[HTML][HTML] Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
Improving the reproducibility of biomedical research is a major challenge. Transparent and
accurate reporting is vital to this process; it allows readers to assess the reliability of the …
accurate reporting is vital to this process; it allows readers to assess the reliability of the …
[HTML][HTML] Late isocaloric eating increases hunger, decreases energy expenditure, and modifies metabolic pathways in adults with overweight and obesity
N Vujović, MJ Piron, J Qian, SL Chellappa… - Cell metabolism, 2022 - cell.com
Late eating has been linked to obesity risk. It is unclear whether this is caused by changes in
hunger and appetite, energy expenditure, or both, and whether molecular pathways in …
hunger and appetite, energy expenditure, or both, and whether molecular pathways in …
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre …
MM Visser, S Charleer, S Fieuws, C De Block… - The Lancet, 2021 - thelancet.com
Background People with type 1 diabetes can continuously monitor their glucose levels on
demand (intermittently scanned continuous glucose monitoring [isCGM]), or in real time (real …
demand (intermittently scanned continuous glucose monitoring [isCGM]), or in real time (real …
A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: A randomized controlled trial …
Objectives: We investigated whether a Mediterranean-style diet (MedDiet) supplemented
with fish oil can improve mental health in adults suffering depression. Methods: Adults with …
with fish oil can improve mental health in adults suffering depression. Methods: Adults with …
Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial
Background Chronic inflammation is believed to be a major mechanism underlying the
pathophysiology of type 2 diabetes. Periodontitis is a cause of systemic inflammation. We …
pathophysiology of type 2 diabetes. Periodontitis is a cause of systemic inflammation. We …
Randomized phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth …
Purpose Uterine serous carcinoma is a rare, aggressive variant of endometrial cancer.
Trastuzumab is a humanized monoclonal antibody that targets human epidermal growth …
Trastuzumab is a humanized monoclonal antibody that targets human epidermal growth …
Effectiveness of belimumab after rituximab in systemic lupus erythematosus: a randomized controlled trial
M Shipa, A Embleton-Thirsk, M Parvaz… - Annals of internal …, 2021 - acpjournals.org
Background: B-cell depletion with rituximab is commonly used for patients with systemic
lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable …
lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable …